Quality of Life Outcomes With Creative Arts Therapy in Children With Cancer. (May 2022)

• Record Type: Journal Article
• Authors: Raybin, Jennifer L.; Zhou, Wenru; Pan, Zhaoxing; Jankowski, Catherine
• Is Part Of: Journal of pediatric hematology/oncology nursing. Volume 39:Number 3(2022)
• Page Start: 155
• Page End: 167
• Publication Date: 2022-05
• Subjects: quality of life -- creative arts therapy -- pediatric -- cancer -- complementary alternative therapy -- posture
• DOI: 10.1177/27527530211055988
• Languages: English
• ISSNs: 2752-7549

Abstract

Introduction : Children with cancer experience distress and decreased quality of life (QOL). Creative arts therapy (CAT) is a therapeutic modality which may improve QOL. This study examined the relationship between CAT and QOL in children and adolescents with cancer. Secondary aims explored relationships between CAT and emotional reactions, resilience, and posture (to investigate future potential as an objective biomarker of QOL).Methods : Children aged 3–18 years undergoing cancer treatments and a parent proxy completed the PedsQL3.0 Cancer Module, Faces Scale for emotional reactions, Resilience Scale in adolescents (>12 years), and an inclinometer to measure thoracic kyphosis before and after CAT. CAT exposure (number of sessions) was recorded.Results : Ninety-eight children with cancer (mean age 7.8 years, range 3–17) and parent proxy were enrolled. Of the 83 participants included in the final analysis, 18 received no CAT, 32 received low dose, and 33 received high dose CAT. A significant improvement in QOL was seen with high dose CAT in (slope change, p = .015), but the overall time by group interaction was not significant. Slope change response patterns suggested that CAT led to improved posture as compared to no CAT (time by group interaction, p = .044).Discussion : CAT may be an effective intervention to improve QOL in this population. Because initial evidence suggests that posture also improves with CAT, further investigation of posture as a potential objective biomarker of QOL is supported. Further study with a randomized controlled trial is warranted.